Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial

Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial

Abstract Background Bioprosthesis has been increasingly implanted for the treatment of transvalvular disease across the world. A new Dafodil™ pericardial bioprosthesis (Meril Life Sciences Pvt. Ltd., India) recently approved by Conformité Européenne (CE) is a tri-leaflet, stented, bovine valve. The...

Full description

Bibliographic Details
Main Authors: C. S. Hiremath, Anil R. Jain, Anurag Garg, Nirmal Gupta, Yugal K. Mishra, Zile Singh Meharwal, Nityanand Thakur, Atul A. Maslekar, Naman Shastri
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Aortic valve
Bioprosthesis
Heart valve prosthesis implantation
Hemodynamic performance
Mitral valve
Quality of life
Online Access:http://link.springer.com/article/10.1186/s13019-020-01154-7

Internet

http://link.springer.com/article/10.1186/s13019-020-01154-7

Similar Items